Conmed CorpNYSE:CNMD
- LAST PRICE74.9500
- TODAY'S CHANGE (%)1.0500 (1.4208%)
- Bid / Lots74.7800/ 4
- Ask / Lots75.3200/ 4
- Open / Previous Close75.0000 / 73.9000
- Day Range
- 52 Week Range
- Volume5,903
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CNMD |
|---|---|---|
| 09:32 ET | 1693 | 75 |
| 09:36 ET | 190 | 74.545 |
| 09:39 ET | 627 | 74.98 |
| 09:41 ET | 556 | 75.2 |
| 09:50 ET | 157 | 75.1 |
| 09:52 ET | 500 | 74.95 |
Sep 3, 2024
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference, from 4:05PM ET on Tuesday Sep 03, 2024 by Dow Jones
4:05PM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Conmed Corp | 2.3B | 23.8x | +8.12% |
Premier Inc | 2.0B | 19.2x | -22.80% |
Myriad Genetics Inc | 2.4B | -14.8x | --- |
Enovis Corp | 2.4B | -22.6x | --- |
LivaNova PLC | 2.8B | -166.8x | --- |
Inari Medical Inc | 2.4B | -42.6x | --- |
Company Information
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Contact Information
- Headquarters
- 11311 Concept BoulevardLARGO, FL, United States 33773
- Phone
- 727-214-2974
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Curt Hartman
- Chief Financial Officer, Executive Vice President - Finance
- Todd Garner
- President, Advanced Surgical and Advanced Endoscopic Technologies
- Stanley Peters
- Chief Operating Officer
- Patrick Beyer
- Chief Human Resource Officer, Executive Vice President, Secretary and Legal Officer
- Heather Cohen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
|---|---|
Revenue (TTM) | $1.3B |
Shares Outstanding | 30.8M |
Dividend Yield | 1.07% |
Annual Dividend Rate | 0.8000 USD |
Ex-Dividend Date | 09-16-24 |
Pay Date | 10-04-24 |
Beta | 1.47 |
EPS | $3.15 |
Book Value | $27.12 |
P/E Ratio | 23.8x |
Price/Sales (TTM) | 1.8 |
Price/Cash Flow (TTM) | 13.4x |
Operating Margin | 12.74% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
